Atlas Trials

A Study to Evaluate the Efficacy and Safety of CREZET Tablet

Clinical trial NCT05889143 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05889143
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Dyslipidemias
Start date
2023-05-24
Primary completion
2024-12-31
Enrollment
15000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.